RxDoctor Payments Data

Jill Campbell

Family · Shenandoah, TXNPI 1164023461

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $165,860 of the $181,808 with a category attached, or 91.2%. AbbVie accounts for 64.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $83,133 and has fallen 52.4% since, to $39,576 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$181,808in general payments, 2019–2025

Across 284 payments — averaging $640.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$118K
  • Galderma Laboratories, L.p.$63K
  • Merz North America, Inc.$998
  • Revance Therapeutics, Inc.$34

What the payments were for

  • Speaking & faculty fees$165,86091%
  • Travel & lodging$9,7345%
  • Food & beverage$6,1403%
  • Education$730%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)192$118,034
Galderma Laboratories, L.p.80$62,741
Merz North America, Inc.11$998
Revance Therapeutics, Inc.1$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$181,808 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Other family in Shenandoah

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →